1. Home
  2. ADVM vs GNS Comparison

ADVM vs GNS Comparison

Compare ADVM & GNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adverum Biotechnologies Inc.

ADVM

Adverum Biotechnologies Inc.

HOLD

Current Price

$4.31

Market Cap

94.6M

Sector

Health Care

ML Signal

HOLD

Logo Genius Group Limited

GNS

Genius Group Limited

HOLD

Current Price

$0.71

Market Cap

81.8M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADVM
GNS
Founded
2006
2002
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
94.6M
81.8M
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
ADVM
GNS
Price
$4.31
$0.71
Analyst Decision
Buy
Analyst Count
5
0
Target Price
$11.60
N/A
AVG Volume (30 Days)
497.5K
6.8M
Earning Date
11-12-2025
09-23-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,749,894.00
Revenue This Year
$1,192.00
$82.78
Revenue Next Year
N/A
$85.90
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.78
$0.21
52 Week High
$6.12
$1.92

Technical Indicators

Market Signals
Indicator
ADVM
GNS
Relative Strength Index (RSI) 58.20 45.50
Support Level $4.15 $0.62
Resistance Level $4.23 $0.79
Average True Range (ATR) 0.09 0.08
MACD 0.02 0.00
Stochastic Oscillator 95.22 55.73

Price Performance

Historical Comparison
ADVM
GNS

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

About GNS Genius Group Limited

Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education, which involves entrepreneur education, management consultancy, and business development tools; and Campus, consisting of resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America. The company derives maximum revenue from Europe/Middle East/Africa.

Share on Social Networks: